SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD
PharmaSHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD is a pharmaceutical company with 1 FDA-approved products.
SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD's Key Drugs
SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD's Recent FDA Approvals
New NDA/BLA approvals for SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD over the last two years — novel drugs only, excluding generics and label supplements.
SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD's Therapeutic Areas
Disease areas where SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD Pipeline Snapshot
Active clinical trials for SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 1